产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 100mg | 95% | 现货 | |||
| 250mg | 95% | 现货 | |||
| 1g | 95% | 现货 | |||
| 5g | 95% | 现货 | |||
| 10g | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 100mg | 95% | 现货 | |||
| 250mg | 95% | 现货 | |||
| 1g | 95% | 现货 | |||
| 5g | 95% | 现货 | |||
| 10g | 95% | 询价 |
CAS No. |
864754-21-2 |
|---|---|
中文名称 |
3-((4-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-1H-吡唑-1-基)甲基)吡啶 |
英文名称 |
3-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine |
别名 |
3-[4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRAZOL-1-YLMETHYL]-PYRIDINE;3-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine;1-(3-PyridylMethyl)-1H-pyrazole-4-boronic acid pinacol ester;3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}pyridine;1-(Pyridin-3-ylmethyl)-1H-pyrazole-4-boronic acid, pinacol ester 97%;Pyridine, 3-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl]-;1-(Pyridin-3-ylmethyl)-1H-pyrazole-4-boronic acid pinacol ester;3-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine - [T25839] |
标准英文名 |
3-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine |
MDL No. |
MFCD08706029 |
分子式 |
C15H20BN3O2 |
分子量 |
285.16 |
精确分子量 |
285.16 |
SMILES |
CC1(C)OB(OC1(C)C)C1=CN(CC2=CC=CN=C2)N=C1 |
标准SMILES |
CC1(C)OB(OC1(C)C)C1C=NN(CC2C=NC=CC=2)C=1 |
性状 |
Form: solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
LVLQAPQDEZOFQU-UHFFFAOYSA-N |
危险类别(旧) |
H302 |
存储要求 |
Keep in dark place, Sealed in dry, Room Temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|